Press Release
<< Back
EMCORE Corporation Announces Financial Results for Fiscal Second Quarter Ended March 31, 2019
- Consolidated Q2 revenue of
$21.7 million - Consolidated Q2 GAAP operating loss of
$5.5 million and Non-GAAP operating loss of$2.2 million - GAAP pre-tax EPS from continuing operations of
$(0.18) and Non-GAAP pre-tax EPS from continuing operations of$(0.07)
“In the second quarter, we continued to deliver on our revenue diversification initiatives with navigation product revenue doubling year over year,”
Financial Highlights - Fiscal Second Quarter Ended March 31, 2019
| Financial Highlights | For the Three Months Ended | |||||||||||
| (in thousands) | March 31, 2019 | December 31, 2018 | March 31, 2018 | |||||||||
| Revenue | $ | 21,745 | $ | 24,001 | $ | 18,623 | ||||||
| GAAP Gross Profit | $ | 5,809 | $ | 5,808 | $ | 4,947 | ||||||
| Non-GAAP Gross Profit | $ | 5,932 | $ | 5,933 | $ | 5,078 | ||||||
| GAAP Operating loss | $ | (5,507 | ) | $ | (5,804 | ) | $ | (3,929 | ) | |||
| Non-GAAP Operating (loss) income | $ | (2,196 | ) | $ | (2,637 | ) | $ | (2,235 | ) | |||
| GAAP pre-tax loss | $ | (4,979 | ) | $ | (5,523 | ) | $ | (3,240 | ) | |||
| Non-GAAP pre-tax (loss) income | $ | (1,972 | ) | $ | (2,370 | ) | $ | (2,072 | ) | |||
| GAAP pre-tax EPS - per diluted share | $ | (0.18 | ) | $ | (0.20 | ) | $ | (0.12 | ) | |||
| Non-GAAP pre-tax EPS - per diluted share | $ | (0.07 | ) | $ | (0.09 | ) | $ | (0.08 | ) | |||
Financial Statement Highlights for the Second Quarter of Fiscal 2019:
- Consolidated revenue was
$21.7 million , representing a 9.4% decrease from the prior quarter - Consolidated GAAP gross margin was 26.7%, representing an increase from 24.2% in the prior quarter
- Consolidated Non-GAAP gross margin was 27.3%, representing an increase from 24.7% in the prior quarter
- Consolidated GAAP operating margin was (25.3)%, representing a decrease from (24.2)% in the prior quarter
- Consolidated Non-GAAP operating margin was (10.1)%, representing an increase from (11.0)% in the prior quarter
- GAAP diluted pre-tax EPS was
$(0.18) , representing an increase from$(0.20) in the prior quarter - Non-GAAP diluted pre-tax EPS was
$(0.07) , representing an increase from$(0.09) in the prior quarter - Cash and cash equivalents were
$50.6 million at the end of the quarter, a decrease of$6.7 million when compared to the end of the prior quarter
Business Outlook
The Company expects revenue for the fiscal third quarter ending June 30, 2019 to be in the range of
Conference Call
The Company will discuss its financial results on May 8, 2019 at
About
Use of Non-GAAP Financial Measures
We disclose non-GAAP gross profit, gross margin percentage, operating income (loss), operating margin percentage, pre-tax EPS and pre-tax income (loss) as a supplemental measure to U.S. GAAP gross profit, gross margin percentage, operating income (loss), operating margin percentage, pre-tax EPS and pre-tax income (loss) regarding our operational performance. These financial measures exclude the impact of certain items that we do not believe are indicative of our core operating results; therefore, they have not been calculated in accordance with U.S. GAAP. A reconciliation of non-GAAP pre-tax income (loss) to GAAP income (loss), which identifies the items excluded from the non-GAAP measures, are provided in the table below titled "Reconciliation of GAAP to Non-GAAP Financial Measures".
We believe that these additional non-GAAP financial measures are useful to investors in assessing our operating performance. We also use these financial measures internally to evaluate our operating performance and for planning and forecasting of future periods. In addition, financial analysts that follow us may focus on and publish both historical results and future projections based on our non-GAAP financial measures. We also believe that it is in the best interests of our investors to provide this non-GAAP information.
While we believe that these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. Our non-GAAP financial measures may not be reported by all of our competitors and they may not be directly comparable to similarly titled measures of other companies due to potential differences in calculation. We compensate for these limitations by using these non-GAAP financial measures as a supplement to U.S. GAAP and by providing a reconciliation of our non-GAAP financial measures to the most comparable U.S. GAAP financial measures.
Non-GAAP financial measures are not in accordance with or an alternative for U.S. GAAP. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable U.S. GAAP financial measures and our disclosures of these measures should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP.
Forward-Looking Statements
The information provided herein may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (“Exchange Act”). These forward-looking statements are largely based on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Such forward-looking statements include, in particular, projections about our future results included in our Exchange Act reports, statements about our plans, strategies, business prospects, changes and trends in our business and the markets in which we operate.
These forward-looking statements may be identified by the use of terms and phrases such as “anticipates”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “plans”, “projects”, “targets”, “will”, and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters such as the development of new products, enhancements or technologies, sales levels, expense levels and other statements regarding matters that are not historical are forward-looking statements. We caution that these forward-looking statements relate to future events or our future financial performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance or achievements of our business or our industry to be materially different from those expressed or implied by any forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: (a) the rapidly evolving markets for the Company's products and uncertainty regarding the development of these markets; (b) the Company's historical dependence on sales to a limited number of customers and fluctuations in the mix of products and customers in any period; (c) delays and other difficulties in commercializing new products; (d) the failure of new products: (i) to perform as expected without material defects, (ii) to be manufactured at acceptable volumes, yields, and cost, (iii) to be qualified and accepted by our customers, and (iv) to successfully compete with products offered by our competitors; (e) uncertainties concerning the availability and cost of commodity materials and specialized product components that we do not make internally; (f) actions by competitors; and (g) other risks and uncertainties discussed under Item 1A - Risk Factors in our Annual Report on Form 10-K for the fiscal year ended September 30, 2018, as updated by our subsequent periodic reports.
Forward-looking statements are based on certain assumptions and analysis made in light of our experience and perception of historical trends, current conditions and expected future developments as well as other factors that we believe are appropriate under the circumstances. While these statements represent our judgment on what the future may hold, and we believe these judgments are reasonable, these statements are not guarantees of any events or financial results. All forward-looking statements in this press release are made as of the date hereof, based on information available to us as of the date hereof, and subsequent facts or circumstances may contradict, obviate, undermine, or otherwise fail to support or substantiate such statements. We caution you not to rely on these statements without also considering the risks and uncertainties associated with these statements and our business that are addressed in our filings with the Securities and Exchange Commission (“SEC”) that are available on the SEC’s web site located at www.sec.gov, including the sections entitled “Risk Factors” in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Certain information included in this press release may supersede or supplement forward-looking statements in our other Exchange Act reports filed with the SEC. We assume no obligation to update any forward-looking statement to conform such statements to actual results or to changes in our expectations, except as required by applicable law or regulation.
EMCORE CORPORATION
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)
| For the Three Months Ended | ||||||||||||
| March 31, 2019 | December 31, 2018 | March 31, 2018 | ||||||||||
| Revenue | $ | 21,745 | $ | 24,001 | $ | 18,623 | ||||||
| Cost of revenue | 15,936 | 18,193 | 13,676 | |||||||||
| Gross profit | 5,809 | 5,808 | 4,947 | |||||||||
| Operating expense: | ||||||||||||
| Selling, general, and administrative | 6,996 | 7,593 | 5,644 | |||||||||
| Research and development | 4,360 | 4,019 | 3,300 | |||||||||
| Loss from change in estimate on ARO obligation | (40 | ) | — | — | ||||||||
| (Gain) loss on sale of assets | — | — | (68 | ) | ||||||||
| Total operating expense | 11,316 | 11,612 | 8,876 | |||||||||
| Operating loss | (5,507 | ) | (5,804 | ) | (3,929 | ) | ||||||
| Other income (expense): | ||||||||||||
| Interest income, net | 224 | 267 | 163 | |||||||||
| Foreign exchange gain (loss) | 304 | 14 | 526 | |||||||||
| Other income | — | — | — | |||||||||
| Total other income (expense) | 528 | 281 | 689 | |||||||||
| Loss before income tax (expense) benefit | (4,979 | ) | (5,523 | ) | (3,240 | ) | ||||||
| Income tax (expense) benefit | (15 | ) | (15 | ) | 169 | |||||||
| Net (loss) income | $ | (4,994 | ) | $ | (5,538 | ) | $ | (3,071 | ) | |||
| Per share data: | ||||||||||||
| Net loss per basic and diluted share | $ | (0.18 | ) | $ | (0.20 | ) | $ | (0.11 | ) | |||
| Weighted-average number of basic and diluted shares outstanding | 27,652 | 27,534 | 27,197 | |||||||||
EMCORE CORPORATION
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
| As of March 31, 2019 |
As of September 30, 2018 |
||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 50,604 | $ | 63,117 | |||||||
| Restricted cash | 33 | 78 | |||||||||
| Accounts receivable, net | 20,131 | 19,275 | |||||||||
| Inventory | 20,672 | 20,850 | |||||||||
| Prepaid expenses and other current assets | 16,392 | 12,730 | |||||||||
| Total current assets | 107,832 | 116,050 | |||||||||
| Property, plant, and equipment, net | 21,095 | 18,216 | |||||||||
| Non-current inventory | 1,114 | 1,433 | |||||||||
| Other non-current assets, net | 84 | 199 | |||||||||
| Total assets | $ | 130,125 | $ | 135,898 | |||||||
| LIABILITIES and SHAREHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 13,321 | $ | 12,997 | |||||||
| Accrued expenses and other current liabilities | 17,381 | 14,205 | |||||||||
| Total current liabilities | 30,702 | 27,202 | |||||||||
| Asset retirement obligations | 1,836 | 1,809 | |||||||||
| Other long-term liabilities | 96 | 82 | |||||||||
| Total liabilities | 32,634 | 29,093 | |||||||||
| Shareholders’ equity: | |||||||||||
| Common stock | 735,257 | 734,066 | |||||||||
| Treasury stock | (47,721 | ) | (47,721 | ) | |||||||
| Accumulated other comprehensive income | 912 | 885 | |||||||||
| Accumulated deficit | (590,957 | ) | (580,425 | ) | |||||||
| Total shareholders’ equity | 97,491 | 106,805 | |||||||||
| Total liabilities and shareholders’ equity | $ | 130,125 | $ | 135,898 | |||||||
We have provided a reconciliation of our non-GAAP pre-tax income (loss) financial measure to its most directly comparable U.S. GAAP financial measure as indicated in the table below:
EMCORE Corporation
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(in thousands, except per share data)
(unaudited)
| For the Three Months Ended | ||||||||||||
| March 31, 2019 | December 31, 2018 | March 31, 2018 | ||||||||||
| US GAAP net loss | $ | (4,994 | ) | $ | (5,538 | ) | $ | (3,071 | ) | |||
| Income tax expense (benefit) | 15 | 15 | (169 | ) | ||||||||
| Other income | — | — | — | |||||||||
| Foreign exchange (gain) loss | (304 | ) | (14 | ) | (526 | ) | ||||||
| Total other income & tax related adjustments | (289 | ) | 1 | (695 | ) | |||||||
| Stock based compensation expense - R&D | 139 | 155 | 166 | |||||||||
| Stock based compensation expense - SG&A | 473 | 159 | 652 | |||||||||
| Litigation and strategic planning related expenses | 2,635 | 2,671 | 174 | |||||||||
| Severance and restructuring charges | (19 | ) | 57 | 639 | ||||||||
| Loss (gain) from change in estimate on ARO obligation | (40 | ) | — | — | ||||||||
| (Gain) loss on sale of assets | — | — | (68 | ) | ||||||||
| Total operating expense adjustments | 3,188 | 3,042 | 1,563 | |||||||||
| ARO accretion | 14 | 14 | 16 | |||||||||
| Stock based compensation expense - COGS | 109 | 111 | 115 | |||||||||
| Total COGS adjustments | 123 | 125 | 131 | |||||||||
| Non-GAAP pre-tax (loss) income | $ | (1,972 | ) | $ | (2,370 | ) | $ | (2,072 | ) | |||
| GAAP EPS - per diluted share | $ | (0.18 | ) | $ | (0.20 | ) | $ | (0.11 | ) | |||
| Other income and tax related adjustments | (0.01 | ) | 0.00 | (0.03 | ) | |||||||
| Operating expense adjustments | 0.12 | 0.11 | 0.06 | |||||||||
| COGS adjustments | 0.00 | 0.00 | 0.00 | |||||||||
| Non-GAAP pre-tax EPS - per diluted share | $ | (0.07 | ) | $ | (0.09 | ) | $ | (0.08 | ) | |||
| GAAP Gross Margin Percentage | 26.7 | % | 24.2 | % | 26.6 | % | ||||||
| Non GAAP Gross Margin Percentage | 27.3 | % | 24.7 | % | 27.3 | % | ||||||
| GAAP Operating Margin Percentage | (25.3 | )% | (24.2 | )% | (21.1 | )% | ||||||
| Non GAAP Operating Margin Percentage | (10.1 | )% | (11.0 | )% | (12.0 | )% | ||||||
Stock-based compensation expense
The effect of recording stock-based compensation expense was as follows:
| Stock-based Compensation Expense | For the Three Months Ended | ||||||||||
| (in thousands) | March 31, 2019 | December 31, 2018 | March 31, 2018 | ||||||||
| Cost of revenue | $ | 109 | $ | 111 | $ | 115 | |||||
| Selling, general, and administrative | 473 | 159 | 652 | ||||||||
| Research and development | 139 | 155 | 166 | ||||||||
| Total stock-based compensation expense | $ | 721 | $ | 425 | $ | 933 | |||||
Contact:
EMCORE Corporation
Mark Gordon
(626) 293-3400
investor@emcore.com
Sapphire Investor Relations, LLC
Erica Mannion or Michael Funari
(617) 542-6180
investor@emcore.com
Source: EMCORE Corporation